Summary of Purpose
This protocol is a large global registry to determine the behaviour of patients with permanent atrial fibrillation (AF) in real-life practice. This will include newly diagnosed patients with permanent AF irrespective of whether or not they receive antiplatelet (anticoagulant or antithrombotic) therapy. In this regard the GARFIELD registry will be unique because it will consider treatment failure in both those who...Read More →
The following dates are available for this trial. Trial information last updated on 23 April 2010.
|1 Dec 2009||18 Mar 2010||Unavailable||1 Sep 2015||1 Apr 2010||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|